EMAP II human
SIGMA/SRP4463 - recombinant, expressed in E. coli, ≥98% (SDS-PAGE)
Synonym: AIMP1; EMAP2; EMAPII; Multisynthetase complex auxiliary component p43; SCYE1
Product Type: Chemical
assay | ≥98% (SDS-PAGE) |
biological source | human |
form | lyophilized |
impurities | endotoxin, tested |
mol wt | ~18.3 kDa |
NCBI accession no. | Q12904 ![]() ![]() |
packaging | pkg of 20 μg |
potency | 20-40 ng/mL |
recombinant | expressed in E. coli |
shipped in | wet ice |
storage temp. | −20°C |
UniProt accession no. | Q12904 ![]() ![]() |
General description: | Endothelial-Monocyte Activating Polypeptide-II (EMAP-II) is a tumor derived cytokine that is an anti-angiogenic factor in tumor vascular development, and strongly inhibits tumor growth. Recombinant human EMAP-II is an 18.3 kDa protein containing 166 amino acid residues. |
Physical form: | Lyophilized from a concentrated (1 mg/ml) solution in water containing 20 mM sodium Phosphate buffer pH 7.5 and 130 mM sodium chloride. |
Reconstitution: | Centrifuge the vial prior to opening. Avoid freeze-thaw cycles. |
Reconstitution: | Reconstitute in water to a concentration of 0.1-1.0 mg/mL. This solution can then be diluted into other aqueous buffers |
Purity | ≥98% (SDS-PAGE) |
Storage Temp. | −20°C |
UNSPSC | 12352200 |